Skip to main content

Phase II Study of the Pan-Deacetylase Inhibitor Panobinostat in Combination with Bortezomib and Dexamethasone in Relapsed and Bortezomib-Refractory Multiple Myeloma (PANORAMA 2)

Publication ,  Conference
Richardson, PG; Alsina, M; Weber, DM; Coutre, SE; Lonial, S; Gasparetto, C; Warsi, G; Ondovik, M; Mukhopadhyay, S; Snodgrass, S; Schlossman, R
Published in: BLOOD
November 18, 2011

Duke Scholars

Published In

BLOOD

ISSN

0006-4971

Publication Date

November 18, 2011

Volume

118

Issue

21

Start / End Page

370 / 371

Location

San Diego, CA

Publisher

AMER SOC HEMATOLOGY

Conference Name

53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Richardson, P. G., Alsina, M., Weber, D. M., Coutre, S. E., Lonial, S., Gasparetto, C., … Schlossman, R. (2011). Phase II Study of the Pan-Deacetylase Inhibitor Panobinostat in Combination with Bortezomib and Dexamethasone in Relapsed and Bortezomib-Refractory Multiple Myeloma (PANORAMA 2). In BLOOD (Vol. 118, pp. 370–371). San Diego, CA: AMER SOC HEMATOLOGY.
Richardson, Paul G., Melissa Alsina, Donna M. Weber, Steven E. Coutre, Sagar Lonial, Cristina Gasparetto, Ghulam Warsi, et al. “Phase II Study of the Pan-Deacetylase Inhibitor Panobinostat in Combination with Bortezomib and Dexamethasone in Relapsed and Bortezomib-Refractory Multiple Myeloma (PANORAMA 2).” In BLOOD, 118:370–71. AMER SOC HEMATOLOGY, 2011.
Richardson PG, Alsina M, Weber DM, Coutre SE, Lonial S, Gasparetto C, et al. Phase II Study of the Pan-Deacetylase Inhibitor Panobinostat in Combination with Bortezomib and Dexamethasone in Relapsed and Bortezomib-Refractory Multiple Myeloma (PANORAMA 2). In: BLOOD. AMER SOC HEMATOLOGY; 2011. p. 370–1.
Richardson PG, Alsina M, Weber DM, Coutre SE, Lonial S, Gasparetto C, Warsi G, Ondovik M, Mukhopadhyay S, Snodgrass S, Schlossman R. Phase II Study of the Pan-Deacetylase Inhibitor Panobinostat in Combination with Bortezomib and Dexamethasone in Relapsed and Bortezomib-Refractory Multiple Myeloma (PANORAMA 2). BLOOD. AMER SOC HEMATOLOGY; 2011. p. 370–371.

Published In

BLOOD

ISSN

0006-4971

Publication Date

November 18, 2011

Volume

118

Issue

21

Start / End Page

370 / 371

Location

San Diego, CA

Publisher

AMER SOC HEMATOLOGY

Conference Name

53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology